Verve Therapeutics
About Us
Why Heart Disease
Approach
Pipeline
Culture & Careers
News
In its first tough test, CRISPR base editing slashes cholesterol levels in monkeys
Post navigation
Previous Post
Previous
A ‘Cure for Heart Disease’? A Single Shot Succeeds in Monkeys
Next Post
Next
Sekar Kathiresan showcases historic monkey data in hunt for a once-and-done gene editing approach to prevent heart attacks
Home
About Us
Why Heart Disease
Approach
Pipeline
Culture & Careers
News
Contact Us